Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
immunotherapy
3
×
indiana blog main
indiana top stories
life sciences
merck
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
bristol-myers squibb
cancer immunotherapy
deals
diagnostics
drug prices
gene therapy
generic drugs
gilead sciences
What
bio
roundup
drug
acquisitions
albert
approval
biggest
biogen’s
biopharma
biopharmaceutical
bourla
car
celgene
ceo
colleagues
companies
company
convo
crispr
earlier
exome
failures
future
government
health
hundreds
imports
industry
littered
maker
maps
measured
medicine
nash
new
news
patients
pfizer
pfizer’s
policy
Language
unknown
Current search:
immunotherapy
×
abbvie
×
merck
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More